Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic CMV-specific T cells

CMV-specific cytotoxic T cells · Milton S. Hershey Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic CMV-specific T cells, covering 2018-05-02 to 2018-05-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) [Phase 1]

See pricing